NCT06563388View on ClinicalTrials.gov

Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial

PHASE3RecruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

September 18, 2024

Primary Completion Date

September 18, 2032

Study Completion Date

September 18, 2032

Conditions
OligometastasisLung CancerColo-rectal CancerProstate Cancer
Interventions
PROCEDURE

Stereotactic Ablative Radiotherapy

Radiation therapy begins after 3 months of Standard of care

OTHER

Best Practice

Receive standard of care therapy

Trial Locations (1)

14263

RECRUITING

Roswell Park Comprehensive Cancer Center, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER